Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
Autor: | Schadendorf, D. *, Amonkar, M.M., Milhem, M., Grotzinger, K., Demidov, L.V., Rutkowski, P., Garbe, C., Dummer, R., Hassel, J.C., Wolter, P., Mohr, P., Trefzer, U., Lefeuvre-Plesse, C., Rutten, A., Steven, N., Ullenhag, G., Sherman, L., Wu, F.S., Patel, K., Casey, M., Robert, C. |
---|---|
Zdroj: | In Annals of Oncology March 2014 25(3):700-706 |
Databáze: | ScienceDirect |
Externí odkaz: |